Arq Neuropsiquiatr
December 2007
Background: Despite not being a common fact, the occurrence of brain tumors during pregnancy poses a risk to both the mother and infant.
Aim: To identify the best medical procedure to be followed for a pregnant patient harboring a brain tumor.
Method: The records of 6 patients with brain tumors, diagnosed during pregnancy were examined.
Objective: The purpose of this study was to complete an evaluation of nevirapine (NVP) toxicity in a cohort of HIV+ pregnant women.
Study Design: This was a retrospective study of 611 women followed from January 1996 to December 2003. All women who used NVP for > 7 days were included.
A cohort of 297 HIV-infected pregnant women was followed from January 1996 to December 2001. The overall transmission rate was 3.57% and remained constant over time.
View Article and Find Full Text PDF